- Nachrichtendetail
-
04.04.2024 12:53:46 - dpa-AFX: *MERCK INITIATES PHASE 3 TRIAL OF MK-1084 WITH FOR FIRST-LINE TREATMENT OF CERTAIN PATIENTS WITH METASTATIC NSCLC
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 129,210 | 13.06.24 21:34:05 | -0,990 | -0,76% | 129,210 | 129,220 | 132,700 | 130,200 |
